Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Coeptis Therapeutics Holdings (COEP) Other Gross PP&E Adjustments (2021 - 2025)

Coeptis Therapeutics Holdings (COEP) has 5 years of Other Gross PP&E Adjustments data on record, last reported at -$3867.0 in Q3 2025.

  • For Q3 2025, Other Gross PP&E Adjustments rose 91.27% year-over-year to -$3867.0; the TTM value through Sep 2025 reached -$3867.0, up 91.27%, while the annual FY2024 figure was -$34546.0, 52.24% up from the prior year.
  • Other Gross PP&E Adjustments reached -$3867.0 in Q3 2025 per COEP's latest filing, up from -$14327.0 in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $7312.0 in Q4 2021 and bottomed at -$72334.0 in Q4 2023.
  • Average Other Gross PP&E Adjustments over 5 years is -$26902.9, with a median of -$24552.0 recorded in 2025.
  • Peak YoY movement for Other Gross PP&E Adjustments: plummeted 1188.66% in 2024, then surged 91.27% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $7312.0 in 2021, then plummeted by 560.57% to -$33677.0 in 2022, then plummeted by 114.79% to -$72334.0 in 2023, then surged by 52.24% to -$34546.0 in 2024, then surged by 88.81% to -$3867.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$3867.0 in Q3 2025, -$14327.0 in Q2 2025, and -$24552.0 in Q1 2025.